Market revenue in 2024 | USD 273.7 million |
Market revenue in 2030 | USD 985.8 million |
Growth rate | 24.3% (CAGR from 2025 to 2030) |
Largest segment | Wearable |
Fastest growing segment | Mobile based Applications |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wearable, Mobile based Applications, Sensors |
Key market players worldwide | Altoida, Koneksa Health, Biogen Inc, Roche Holding AG, NeuraMetrix, Merck KGaA, Linus Health, Neurotrack, Huma, NeuraLight |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital neuro biomarkers market will help companies and investors design strategic landscapes.
Wearable was the largest segment with a revenue share of 49.98% in 2024. Horizon Databook has segmented the North America digital neuro biomarkers market based on wearable, mobile based applications, sensors covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America digital neuro biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into North America digital neuro biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account